Breaking News Instant updates and real-time market news.

UBER

Uber

$37.07 /

-0.54 (-1.44%)

08:53
01/23/20
01/23
08:53
01/23/20
08:53

Uber price target raised to $45 from $40 at Guggenheim

After Uber announced that it sold its India delivery business to Zomato, Guggenheim analyst Jake Fuller noted that stripping out the associated losses increased his 2020 EBITDA estimate to negative $1.8B from negative $2B and he now projects Uber can turn EBITDA positive in the second quarter of 2021. The analyst, who believes the delivery category appears to be in the early stages of rationalization, keeps a Buy rating on Uber shares and raised his price target on the stock to $45 from $40 given the improving visibility on a path to profitability.

  • 06

    Feb

UBER Uber
$37.07 /

-0.54 (-1.44%)

01/21/20 JMP Securities
Uber's sale of its India business removes overhang, says JMP Securities
01/21/20 Stifel
Uber financial discipline should bring higher multiples, says Stifel
01/21/20 Wedbush
Uber's sale of Indian food delivery business 'smart,' says Wedbush
01/17/20 Stifel
Uber price target raised to $40 from $34 at Stifel

TODAY'S FREE FLY STORIES

Recommendations
L Brands price target raised to $28 from $23 at Goldman Sachs » 07:15
02/24/20
02/24
07:15
02/24/20
07:15
LB

L Brands

$24.06 /

+0.63 (+2.69%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anavex announces publication of foundational data for ANAVEX 2-73 in MS » 07:15
02/24/20
02/24
07:15
02/24/20
07:15
AVXL

Anavex

$5.08 /

-0.08 (-1.55%)

Anavex Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sabra Health Care reports Q4 EPS 20c, consensus 20c » 07:14
02/24/20
02/24
07:14
02/24/20
07:14
SBRA

Sabra Health Care

$22.00 /

-0.135 (-0.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Galapagos price target raised to $302 from $205 at H.C. Wainwright » 07:14
02/24/20
02/24
07:14
02/24/20
07:14
GLPG

Galapagos

$273.79 /

+13.47 (+5.17%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sapiens sees FY20 revenue $377M-$383M, consensus $364.81M » 07:13
02/24/20
02/24
07:13
02/24/20
07:13
SPNS

Sapiens

$25.60 /

+0.07 (+0.27%)

"The Sapiens global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cooper Tire sees 'modest global unit volume increase' in FY20 » 07:13
02/24/20
02/24
07:13
02/24/20
07:13
CTB

Cooper Tire

$26.80 /

-0.45 (-1.65%)

Sees capital expenditure…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Digital Ally announces oral argument date for appeal in Axon litigation » 07:12
02/24/20
02/24
07:12
02/24/20
07:12
DGLY

Digital Ally

$1.40 /

-0.03 (-2.10%)

, AAXN

Axon

$86.10 /

-0.32 (-0.37%)

Digital Ally, Inc. (DGLY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sapiens reports Q4 adjusted EPS 21c, consensus 20c » 07:12
02/24/20
02/24
07:12
02/24/20
07:12
SPNS

Sapiens

$25.60 /

+0.07 (+0.27%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Intersect ENT backs FY20 revenue guidance of $115M-$119M, consensus $119.41M  07:11
02/24/20
02/24
07:11
02/24/20
07:11
XENT

Intersect ENT

$26.77 /

-0.79 (-2.87%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Pacira price target raised to $63 from $60 at H.C. Wainwright » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
PCRX

Pacira

$48.46 /

-1.54 (-3.08%)

, HRTX

Heron Therapeutics

$21.43 /

+0.38 (+1.81%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cooper Tire CEO sees 'momentum to make greater progress' on initiatives » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
CTB

Cooper Tire

$26.80 /

-0.45 (-1.65%)

CEO Brad Hughes says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ContraFect receives Breakthrough Therapy designation for Exebacase » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
CFRX

ContraFect

$11.10 /

+0.3 (+2.78%)

ContraFect Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Technologies price target lowered to $172 from $177 at Credit Suisse » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
UTX

United Technologies

$151.53 /

+1.58 (+1.05%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rocket Pharmaceuticals announces publication regarding FA treatment approach » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

Rocket Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Intersect ENT reports Q4 EPS (25c), consensus (35c) » 07:11
02/24/20
02/24
07:11
02/24/20
07:11
XENT

Intersect ENT

$26.77 /

-0.79 (-2.87%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paratek announces license grant to Almirall for SEYSARA in Greater China » 07:10
02/24/20
02/24
07:10
02/24/20
07:10
PRTK

Paratek Pharmaceuticals

$3.56 /

-0.01 (-0.28%)

Paratek Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cooper Tire reports Q EPS $1.02, consensus 67c » 07:09
02/24/20
02/24
07:09
02/24/20
07:09
CTB

Cooper Tire

$26.80 /

-0.45 (-1.65%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Altair appoints Gilma Saravia as CPO » 07:08
02/24/20
02/24
07:08
02/24/20
07:08
ALTR

Altair

$36.32 /

-1.47 (-3.89%)

, APTV

Aptiv

$90.08 /

-1.03 (-1.13%)

Altair (ALTR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Ascendis risk/reward into data skewed to downside, says Cantor Fitzgerald » 07:08
02/24/20
02/24
07:08
02/24/20
07:08
ASND

Ascendis Pharma

/

+

With Ascendis Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Credit Karma potential deal shows rising importance of FinApps, says KeyBanc » 07:08
02/24/20
02/24
07:08
02/24/20
07:08
INTU

Intuit

$297.77 /

-3.47 (-1.15%)

, V

Visa

$208.78 /

-2.615 (-1.24%)

, SQ

Square

$83.52 /

-2.22 (-2.59%)

, PYPL

PayPal

$119.47 /

-3.03 (-2.47%)

KeyBanc analyst Josh Beck…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CarGurus price target lowered to $41 from $55 at SunTrust » 07:07
02/24/20
02/24
07:07
02/24/20
07:07
CARG

CarGurus

$27.61 /

-0.62 (-2.20%)

SunTrust analyst Naved…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Colony Bank to acquire Cadence's East Georgia Homebuilder Finance portfolio » 07:07
02/24/20
02/24
07:07
02/24/20
07:07
CBAN

Colony Bankcorp

$15.00 /

-0.09 (-0.60%)

, CADE

Cadence Bancorp

$16.62 /

-0.4 (-2.35%)

Colony Bankcorp (CBAN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lipocine announces regulatory path for Tlando » 07:07
02/24/20
02/24
07:07
02/24/20
07:07
LPCN

Lipocine

$0.46 /

-0.0116 (-2.46%)

Lipocine announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Dorman Products expects to face 'difficult comparisons' in Q1 » 07:05
02/24/20
02/24
07:05
02/24/20
07:05
DORM

Dorman Products

$76.94 /

+0.68 (+0.89%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Dorman Products sees FY20 adj. EPS $3.35-$3.55, consensus $3.84 » 07:04
02/24/20
02/24
07:04
02/24/20
07:04
DORM

Dorman Products

$76.94 /

+0.68 (+0.89%)

Sees net sales growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.